Papapoulos S - Search Results

1

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.

Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Fitzpatrick LA, Mitlak B, Papapoulos S, Rizzoli R, Dore RK, Bilezikian JP, Saag KG. Bone HG, et al. Among authors: papapoulos s. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2949-2957. doi: 10.1210/jc.2018-00163. J Clin Endocrinol Metab. 2018. PMID: 29800372 Free PMC article. Clinical Trial.

2

[Diphosphonates in the treatment of osteoporosis].

Papapoulos S. Papapoulos S. Ther Umsch. 1991 Feb;48(2):100-6. Ther Umsch. 1991. PMID: 1903565 German.

3

The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men.

Kok DJ, Iestra JA, Doorenbos CJ, Papapoulos SE. Kok DJ, et al. Among authors: papapoulos se. J Clin Endocrinol Metab. 1990 Oct;71(4):861-7. doi: 10.1210/jcem-71-4-861. J Clin Endocrinol Metab. 1990. PMID: 2401715

4

Recovery of serum calcium concentrations following acute hypocalcemia in patients with osteoporosis on long-term oral therapy with the bisphosphonate pamidronate.

Landman JO, Schweitzer DH, Frölich M, Hamdy NA, Papapoulos SE. Landman JO, et al. Among authors: papapoulos se. J Clin Endocrinol Metab. 1995 Feb;80(2):524-8. doi: 10.1210/jcem.80.2.7852514. J Clin Endocrinol Metab. 1995. PMID: 7852514 Clinical Trial.

5

Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.

Schweitzer DH, Hamdy NA, Frölich M, Zwinderman AH, Papapoulos SE. Schweitzer DH, et al. Among authors: papapoulos se. Clin Endocrinol (Oxf). 1994 Aug;41(2):251-6. doi: 10.1111/j.1365-2265.1994.tb02538.x. Clin Endocrinol (Oxf). 1994. PMID: 7923831

6

The role of bisphosphonates in the prevention and treatment of osteoporosis.

Papapoulos SE. Papapoulos SE. Am J Med. 1993 Nov 30;95(5A):48S-52S. doi: 10.1016/0002-9343(93)90383-z. Am J Med. 1993. PMID: 8256796 Review.

7

Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate.

Landman JO, Hamdy NA, Pauwels EK, Papapoulos SE. Landman JO, et al. Among authors: papapoulos se. J Clin Endocrinol Metab. 1995 Dec;80(12):3465-8. doi: 10.1210/jcem.80.12.8530584. J Clin Endocrinol Metab. 1995. PMID: 8530584

8

Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.

Papapoulos SE, Frölich M. Papapoulos SE, et al. J Clin Endocrinol Metab. 1996 Nov;81(11):3993-7. doi: 10.1210/jcem.81.11.8923849. J Clin Endocrinol Metab. 1996. PMID: 8923849

9

Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension.

Brumsen C, Papapoulos SE, Lips P, Geelhoed-Duijvestijn PH, Hamdy NA, Landman JO, McCloskey EV, Netelenbos JC, Pauwels EK, Roos JC, Valentijn RM, Zwinderman AH. Brumsen C, et al. J Bone Miner Res. 2002 Jun;17(6):1057-64. doi: 10.1359/jbmr.2002.17.6.1057. J Bone Miner Res. 2002. PMID: 12054161 Free article. Clinical Trial.

10

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women.

Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE. Papapoulos SE, et al. Osteoporos Int. 2005 May;16(5):468-74. doi: 10.1007/s00198-004-1725-z. Epub 2004 Sep 21. Osteoporos Int. 2005. PMID: 15448985 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page